CTLA4 and neoplasm: Interestingly, ALDOA-high tumors exhibited lower expression of most immune checkpoint genes, including PDCD1 (PD-1), CTLA4, TIGIT and LAG3, suggesting that ALDOA overexpression may reduce immune checkpoint activity, potentially promoting immune evasion by decreasing immune cell engagement with the tumor.